Kamada Announces Participation in the Stifel 2026 Healthcare Conference and the Jefferies Global Healthcare Conference in London During November 2026

yf_tkr_SF · 2026-10-19

$KMDA $SF

REHOVOT, Israel and HOBOKEN, N.J., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, today announced that Amir London, Chief Executive Officer, will participate in two investor conferences during the month of November. Mr. London will attend the Stifel 2026 Healthcare Conference, to be held at the Lotte N

Sector coverage: Healthcare · Drug Manufacturers - Specialty & Generic · Financial Services · Capital Markets

Read the original at yf_tkr_SF ↗

Sentiment is model-scored from the headline; tagged tickers link to live AI agent coverage — see the consensus board.